Related references
Note: Only part of the references are listed.Characterisation of agonist signalling profiles and agonist-dependent antagonism at PACAP-responsive receptors: Implications for drug discovery
Zoe Tasma et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Plasma levels of vasoactive neuropeptides in pediatric patients with migraine during attack and attack-free periods
Fatma Hanci et al.
CEPHALALGIA (2021)
A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention
Messoud Ashina et al.
CEPHALALGIA (2021)
Increase in trigeminal ganglion neurons that respond to both calcitonin gene-related peptide and pituitary adenylate cyclase-activating polypeptide in mouse models of chronic migraine and posttraumatic headache
Zhaohua Guo et al.
PAIN (2021)
Amylin Analog Pramlintide Induces Migraine-like Attacks in Patients
Hashmat Ghanizada et al.
ANNALS OF NEUROLOGY (2021)
PACAP-PAC1 Signaling Regulates Serotonin 2A Receptor Internalization
Atsuko Hayata-Takano et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Diagnosis and Management of Headache: A Review
Matthew S. Robbins
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
A guide to accurate reporting in digital image acquisition – can anyone replicate your microscopy data?
John M. Heddleston et al.
JOURNAL OF CELL SCIENCE (2021)
New phosphosite-specific antibodies to unravel the role of GRK phosphorylation in dopamine D2 receptor regulation and signaling
Anika Mann et al.
SCIENTIFIC REPORTS (2021)
Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches A Randomized Clinical Trial
Lanfranco Pellesi et al.
JAMA NETWORK OPEN (2021)
PACAP27 induces migraine-like attacks in migraine patients
Hashmat Ghanizada et al.
CEPHALALGIA (2020)
PAC1receptor blockade reduces central nociceptive activity: new approach for primary headache?
Jan Hoffmann et al.
PAIN (2020)
ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
Elliott Lilley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers
Lanfranco Pellesi et al.
CEPHALALGIA (2020)
Differences in pituitary adenylate cyclase-activating peptide and calcitonin gene-related peptide release in the trigeminovascular system
Jacob Carl Alexander Edvinsson et al.
CEPHALALGIA (2020)
Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review
Cecilia Rustichelli et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Nathalie Percie du Sert et al.
PLOS BIOLOGY (2020)
Combinatorial expression of GPCR isoforms affects signalling and drug responses
Maria Marti-Solano et al.
NATURE (2020)
Designing a rigorous microscopy experiment: Validating methods and avoiding bias
Anna Payne-Tobin Jost et al.
JOURNAL OF CELL BIOLOGY (2019)
CGRP and the Trigeminal System in Migraine
Smriti Iyengar et al.
HEADACHE (2019)
GPCRomics: An Approach to Discover GPCR Drug Targets
Paul A. Insel et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
PAC1 receptor mRNA and protein distribution in rat and human trigeminal and sphenopalatine ganglia, spinal trigeminal nucleus and in dura mater
Kelly Hensley et al.
CEPHALALGIA (2019)
Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: Relevant to migraine
Qing Zhang et al.
MOLECULAR PAIN (2019)
If this is true, what does it imply? How end-user antibody validation facilitates insights into biology and disease
Karen S. Sfanos et al.
ASIAN JOURNAL OF UROLOGY (2019)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Expression of Pituitary Adenylate Cyclase-activating Peptide, Calcitonin Gene-related Peptide and Headache Targets in the Trigeminal Ganglia of Rats and Humans
Simona Denise Frederiksen et al.
NEUROSCIENCE (2018)
Enhanced validation of antibodies for research applications
Fredrik Edfors et al.
NATURE COMMUNICATIONS (2018)
An overview of technical considerations for Western blotting applications to physiological research
J. J. Bass et al.
SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS (2017)
Chronic changes in pituitary adenylate cyclase-activating polypeptide and related receptors in response to repeated chemical dural stimulation in rats
Xun Han et al.
MOLECULAR PAIN (2017)
PAC1-and VPAC2 receptors in light regulated behavior and physiology: Studies in single and double mutant mice
Jens Hannibal et al.
PLOS ONE (2017)
On the Dependency of Cellular Protein Levels on mRNA Abundance
Yansheng Liu et al.
CELL (2016)
A proposal for validation of antibodies
Mathias Uhlen et al.
NATURE METHODS (2016)
Engineering therapeutic antibodies targeting G-protein-coupled receptors
Migyeong Jo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management
Folabomi A. Oladosu et al.
MAYO CLINIC PROCEEDINGS (2015)
STIMULATORY EFFECT OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE 6-38, M65 AND VASOACTIVE INTESTINAL POLYPEPTIDE 6-28 ON TRIGEMINAL SENSORY NEURONS
E. Saghy et al.
NEUROSCIENCE (2015)
RNA-Seq Analysis of Human Trigeminal and Dorsal Root Ganglia with a Focus on Chemoreceptors
Caroline Flegel et al.
PLOS ONE (2015)
A second trigeminal CGRP receptor: function and expression of the AMY1 receptor
Christopher S. Walker et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
VPAC2 receptor expression in human normal and neoplastic tissues: evaluation of the novel MAB SP235
Stefan Schulz et al.
ENDOCRINE CONNECTIONS (2015)
Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38
Faisal Mohammad Amin et al.
BRAIN (2014)
PACAP receptor pharmacology and agonist bias: analysis in primary neurons and glia from the trigeminal ganglia and transfected cells
C. S. Walker et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Proper Application of Antibodies for Immunohistochemical Detection: Antibody Crimes and How to Prevent Them
Richard Ivell et al.
ENDOCRINOLOGY (2014)
Controls for Immunohistochemistry: The Histochemical Society's Standards of Practice for Validation of Immunohistochemical Assays
Stephen M. Hewitt et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2014)
PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor
Inger Jansen-Olesen et al.
NEUROPEPTIDES (2014)
Pituitary adenylate cyclase activating polypeptide and migraine
Alessandro S. Zagami et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients
Bernadett Tuka et al.
CEPHALALGIA (2013)
Alternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity
Janna Blechman et al.
Frontiers in Endocrinology (2013)
Consequences of splice variation on Secretin family G protein-coupled receptor function
Sebastian G. B. Furness et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1
Anthony J. Harmar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Specificity Controls for Immunocytochemistry: The Antigen Preadsorption Test Can Lead to Inaccurate Assessment of Antibody Specificity
Silvia Holmseth et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
DISTRIBUTION OF VASOACTIVE INTESTINAL PEPTIDE, PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE, NITRIC OXIDE SYNTHASE, AND THEIR RECEPTORS IN HUMAN AND RAT SPHENOPALATINE GANGLION
A. Csati et al.
NEUROSCIENCE (2012)
Characterization of Intestinal and Pancreatic Dysfunction in VPAC1-Null Mutant Mouse
Dorit Fabricius et al.
PANCREAS (2011)
Antibody validation
Jennifer Bordeaux et al.
BIOTECHNIQUES (2010)
PACAP38 induces migraine-like attacks in patients with migraine without aura
Henrik Winther Schytz et al.
BRAIN (2009)
Alternative splicing of G protein-coupled receptors: physiology and pathophysiology
Danijela Markovic et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
A Guide to the Perplexed on the Specificity of Antibodies
Clifford B. Saper
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
Rescue of Functional F508del Cystic Fibrosis Transmembrane Conductance Regulator by Vasoactive Intestinal Peptide in the Human Nasal Epithelial Cell Line JME/CF15
Sara Rafferty et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
How reliable are G-protein-coupled receptor antibodies?
Martin C. Michel et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies
S Schulz et al.
CLINICAL CANCER RESEARCH (2004)
Expression of the receptor for pituitary adenylate cyclase-activating polypeptide (PAC1-R) in reactive astrocytes
R Suzuki et al.
MOLECULAR BRAIN RESEARCH (2003)
Expression of VPAC2 receptor and PAC1 receptor splice variants in the trigeminal ganglion of the adult rat
P Chaudhary et al.
MOLECULAR BRAIN RESEARCH (2002)
The VPAC2 receptor is essential for circadian function in the mouse suprachiasmatic nuclei
AJ Harmar et al.
CELL (2002)
Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia
M Knutsson et al.
NEUROREPORT (2002)
Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2
R Uddman et al.
CEPHALALGIA (2002)
Impairment of mossy fiber long-term potentiation and associative learning in pituitary adenylate cyclase activating polypeptide type I receptor-deficient mice
C Otto et al.
JOURNAL OF NEUROSCIENCE (2001)
Desensitization, surface expression, and glycosylation of a functional, epitope-tagged type IPACAP (PAC1) receptor
N Shintani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2000)
PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance
F Jamen et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
